Trial NCT03949842

View at ClinicalTrials.gov 
Org. Study IDs: 206860

Last trial update was posted on 2020-04-22

MeSH Interventions

Adrenergic Agents Cholinergic Agents Fluticasone Muscarinic Antagonists Xhance

MeSH Conditions

Lung Diseases Pulmonary Disease, Chronic Obstructive

Other Conditions


Stopping Reasons

The decision to end the study was based on a change in GSK strategy. No subjects were enrolled into the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID